首页> 美国卫生研究院文献>Journal of Biomedical Research >A novel SATB1 binding site in the BCL2 promoter region possesses transcriptional regulatory function
【2h】

A novel SATB1 binding site in the BCL2 promoter region possesses transcriptional regulatory function

机译:BCL2启动子区域中的新型SATB1结合位点具有转录调控功能

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BCL2 is a key regulator of apoptosis. Our previous work has demonstrated that special AT-rich sequence-binding protein 1 (SATB1) is positively correlated with BCL2 expression. In the present study, we report a new SATB1 binding site located between P1 and P2 promoters of the BCL2 gene. The candidate SATB1 binding sequence predicted by bioinformatic analysis was investigated in vitro and in vivo by electrophoretic gel mobility shift assays (EMSA) and chromatin immunoprecipitation (ChIP). One 25-bp sequence, named SB1, was confirmed to be SATB1 binding site. The regulatory function of SB1 and its relevance to SATB1 were further examed with dual-luciferase reporter assay system in Jurkat cells. We found that SB1 could negatively regulate reporter gene activity. Mutation of SATB1 binding site further repressed the activity. Knockdown of SATB1 also enhanced this negative effect of SB1. Our data indicate that the SB1 sequence possesses negative transcriptional regulatory function and this function can be antagonized by SATB1.
机译:BCL2是凋亡的关键调节因子。我们以前的工作表明,特殊的富含AT的序列结合蛋白1(SATB1)与BCL2表达呈正相关。在本研究中,我们报告了位于BCL2基因的P1和P2启动子之间的新的SATB1结合位点。通过生物信息学分析预测的候选SATB1结合序列在体外和体内通过电泳迁移率测定(EMSA)和染色质免疫沉淀(ChIP)进行了研究。一个25 bp的序列,称为SB1,被证实是SATB1结合位点。用Jurkat细胞中的双荧光素酶报告基因检测系统进一步检查了SB1的调节功能及其与SATB1的相关性。我们发现SB1可以负调控记者基因活性。 SATB1结合位点的突变进一步抑制了该活性。击倒SATB1也增强了SB1的负面影响。我们的数据表明,SB1序列具有负转录调节功能,并且该功能可以被SATB1拮抗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号